Latest / The Future of HIV Care
Joel Gallant: Where Will Antiretroviral Therapy Go Next?
After years of relatively little movement on the HIV treatment front, we're entering a new period of activity, as fresh FDA drug approvals begin to roll in and the research pipeline grows more intriguing. Longtime clinician-researcher Joel Gallant, M.D., M.P.H., joins us to discuss the current wave of two-drug regimens; the long-acting options on the (not-too-distant) horizon; and the impact of all of this on the conversations you'll have with your patients regarding HIV treatment strategy, drug resistance, and more.
Please support the pod by checking out the online summary/transcript of this…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.